Article metrics

  • citations in SCindeks: [1]
  • citations in CrossRef:0
  • citations in Google Scholar:[=>]
  • visits in previous 30 days:2
  • full-text downloads in 30 days:0
article: 6 from 12  
Back back to result list
Medicinski pregled
2017, vol. 70, iss. 9-10, pp. 319-323
article language: English
document type: Case Report
published on: 15/12/2017
doi: 10.2298/MPNS1710319P
The outcome of Pneumocystis jiroveci pneumonia complicated with ventilator-associated pneumonia in a patient suffering from acquired immunodeficiency syndrome: A case report
aUniversity of Kragujevac, Faculty of Medicine
bUniversity of Kragujevac, Faculty of Medicine + Clinical Centre Kragujevac, Clinic for Infectious Diseases
cUniversity of Kragujevac, Faculty of Medicine, Department of Pathophysiology

e-mail: sara.nikolic.kv@gmail.com

Abstract

Introduction. The respiratory tract is the most common site of opportunistic infections in patients with acquired immunodeficiency syndrome, and respiratory failure is the leading cause of death in these cases. In addition, the use of mechanical ventilation in the treatment of respiratory failure carries a high risk of nosocomial pneumonia caused by multidrug-resistant strains of bacteria. Case report. We present a human immunodeficiency virus-positive patient with positive outcome of Pneumocystis jiroveci pneumonia whose condition progressed to acute respiratory distress syndrome with the development of complications associated with mechanical ventilation. As soon as an opportunistic infection was suspected, trimethoprim-sulfamethoxazole and corticosteroid therapy were initiated, with a short application of mechanical ventilation. Despite a good initial response to treatment, during the mechanical ventilation, a relapse of fever occurred, as well as development of productive cough, new zones of consolidation on chest X-ray and Acinetobacter spp. was isolated in a swab culture. According to the literature recommendations, colistin-meropenem combination was conducted with adequate response. The patient was discharged after 22 days of treatment, in good general condition, afebrile, with normal laboratory parameters and gas exchange, without subjective symptoms. Conclusion. Early identification of Pneumocystis jiroveci pneumonia, timely initiation of prophylaxis and treatment, along with antiretroviral therapy, reduced the risk of severe clinical events and respiratory failure. Also, timely recognition of complications of mechanical ventilation, identification of infection, early extubation and application of appropriate antibiotic therapy, reduce the mortality from nosocomial pneumonia caused by multi-drug resistant hospital strains of microorganisms.

Keywords

References

American Thoracic Society, Infectious Diseases Society of America (2005) Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia. American Journal of Respiratory and Critical Care Medicine, 171(4): 388-416
Barbier, F., Coquet, I., Legriel, S., Pavie, J., Darmon, M., Mayaux, J., Molina, J., Schlemmer, B., Azoulay, É. (2009) Etiologies and outcome of acute respiratory failure in HIV-infected patients. Intensive Care Medicine, 35(10): 1678-1686
Barry, S., Lipman, M., Deery, A., Johnson, M., Janossy, G. (2002) Immune reconstitution pneumonitis following Pneumocystis carinii pneumonia in HIV-infected subjects. HIV Medicine, 3(3): 207-211
CDC-Healthcare Infection Control Practices Advisory Committee, Tablan, O.C., Anderson, L.J., Besser, R., Bridges, C., Hajjeh, R. (2004) Guidelines for preventing health-care: Associated pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep, 53(RR-3):1-36
Chastre, J., Fagon, J. (2002) Ventilator-associated Pneumonia. American Journal of Respiratory and Critical Care Medicine, 165(7): 867-903
Ewald, H., Raatz, H., Boscacci, R., Furrer, H., Bucher, H.C., Briel, M. (2015) Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection. Cochrane Database Syst Rev., (4):CD006150
Kaplan, J.E., Benson, C., Holmes, K.H., Brooks, J.T., Pau, A., Masur, H. (2009) Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases. MMWR Recomm Rep, 58(RR-4), str. 1-207
Karageorgopoulos, D.E., Falagas, M.E. (2008) Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infectious Diseases, 8(12): 751-762
Kasper, D.L., Fauci, A.S., Hauser, S.L., Longo, D.L., Jameson, J.L., Loscalzo, J., ur. (2015) Harrison's principles of internal medicine. New York, NY: McGraw-Hill, 19th ed
Llibre, J.M., Revollo, B., Vanegas, S., Lopez-Nuñez, J.J., Ornelas, A., Marin, J.M., Santos, J.R., Marte, P., Morera, M., Zuluaga, P., Tor, J., Clotet, B. (2013) Pneumocystis jirovecii pneumonia in HIV-1-infected patients in the late-HAART era in developed countries. Scandinavian Journal of Infectious Diseases, 45(8): 635-644
Mansharamani, N.G., Garland, R., Delaney, D., Koziel, H. (2000) Management and Outcome Patterns for Adult Pneumocystis carinii Pneumonia, 1985 to 1995. Chest, 118(3): 704-711
Morris, A., Wachter, R.M., Luce, J., Turner, J., Huang, L. (2003) Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS, 17(1): 73-80
Nseir, S., di Pompeo, C., Pronnier, P., Beague, S., Onimus, T., Saulnier, F., Grandbastien, B., Mathieu, D., Delvallez-Roussel, M., Durocher, A. (2002) Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome. European Respiratory Journal, 20(6): 1483-1489
Peek, G.J., Clemens, F., Elbourne, D., Firmin, R., Hardy, P., Hibbert, C., Killer, H., Mugford, M., Thalanany, M., Tiruvoipati, R., Truesdale, A., Wilson, A. (2006) CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure. BMC Health Services Research, 6(1): 163
Rodriguez, C.H., de Ambrosio, A., Bajuk, M., Spinozzi, M., Nastro, M., Bombicino, K., Radice, M., Gutkind, G., Vay, C., Famiglietti, A. (2010) In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones. Journal of infection in developing countries, 4(3): 164-7
Roembke, F., Heinzow, H.S., Gosseling, T., Heinecke, A., Domagk, D., Domschke, W., Meister, T. (2014) Clinical outcome and predictors of survival in patients with pneumocystis jirovecii pneumonia--results of a tertiary referral centre. clinical respiratory journal, 8(1): 86-92
Stefan-Mikić, S. (2017) Ispitivanje osetljivosti Acinetobacter spp na antimikrobne lekove u periodu 2012-2015. godine. Medicinski pregled, vol. 70, br. 3-4, str. 99-106
Walzer, P. D., Evans, H. E. R., Copas, A. J., Edwards, S. G., Grant, A. D., Miller, R. F. (2008) Early Predictors of Mortality from Pneumocystis jirovecii Pneumonia in HIV-Infected Patients: 1985-2006. Clinical Infectious Diseases, 46(4): 625-633
Zolopa, A.R., Andersen, J., Komarow, L., Sanne, I., Sanchez, A., Hogg, E., Suckow, C., Powderly, W. (2009) Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial. PLoS ONE, 4(5): e5575